Novel role for carbohydrate responsive element binding protein in the control of ethanol metabolism and susceptibility to binge drinking
Potential conflict of interest: Nothing to report.
Supported by grants from ANR (ANR‐09‐GENO‐011‐HEPACOL, ANR‐09‐JCJC‐057‐01 [Dentin]), the Fondation Française de la Recherche Médicale (Labélisation Equipe), Ville de Paris, and the European Commission (FLORINASH, FP7 project).
Abstract
Carbohydrate responsive element binding protein (ChREBP) is central for de novo fatty acid synthesis under physiological conditions and in the context of nonalcoholic fatty liver disease. We explored its contribution to alcohol‐induced steatosis in a mouse model of binge drinking as acute ethanol (EtOH) intoxication has become an alarming health problem. Within 6 hours, ChREBP acetylation and its recruitment onto target gene promoters were increased in liver of EtOH‐fed mice. Acetylation of ChREBP was dependent on alcohol metabolism because inhibition of alcohol dehydrogenase (ADH) activity blunted ChREBP EtOH‐induced acetylation in mouse hepatocytes. Transfection of an acetylation‐defective mutant of ChREBP (ChREBPK672A) in HepG2 cells impaired the stimulatory effect of EtOH on ChREBP activity. Importantly, ChREBP silencing in the liver of EtOH‐fed mice prevented alcohol‐induced triglyceride accumulation through an inhibition of the lipogenic pathway but also led, unexpectedly, to hypothermia, increased blood acetaldehyde concentrations, and enhanced lethality. This phenotype was associated with impaired hepatic EtOH metabolism as a consequence of reduced ADH activity. While the expression and activity of the NAD+ dependent deacetylase sirtuin 1, a ChREBP‐negative target, were down‐regulated in the liver of alcohol‐fed mice, they were restored to control levels upon ChREBP silencing. In turn, ADH acetylation was reduced, suggesting that ChREBP regulates EtOH metabolism and ADH activity through its direct control of sirtuin 1 expression. Indeed, when sirtuin 1 activity was rescued by resveratrol pretreatment in EtOH‐treated hepatocytes, a significant decrease in ADH protein content and/or acetylation was observed. Conclusion: our study describes a novel role for ChREBP in EtOH metabolism and unravels its protective effect against severe intoxication in response to binge drinking. (Hepatology 2015;62:1086‐1100)
Number of times cited: 20
- Adeline Bertola, Rodent models of fatty liver diseases, Liver Research, 10.1016/j.livres.2018.03.001, (2018).
- Ibraheem Ali, Ryan J. Conrad, Eric Verdin and Melanie Ott, Lysine Acetylation Goes Global: From Epigenetics to Metabolism and Therapeutics, Chemical Reviews, (2018).
- Deqiang Zhang, Xin Tong, Bradley B. Nelson, Ethan Jin, Julian Sit, Nicholas Charney, Meichan Yang, M. Bishr Omary and Lei Yin, The hepatic BMAL1/AKT/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPARα pathway, Hepatology, 68, 3, (883-896), (2018).
- Karim Gariani, Dongryeol Ryu, Keir J. Menzies, Hyon-Seung Yi, Sokrates Stein, Hongbo Zhang, Alessia Perino, Vera Lemos, Elena Katsyuba, Pooja Jha, Sandrine Vijgen, Laura Rubbia-Brandt, Yong Kyung Kim, Jung Tae Kim, Koon Soon Kim, Minho Shong, Kristina Schoonjans and Johan Auwerx, Inhibiting poly ADP-ribosylation increases fatty acid oxidation and protects against fatty liver disease, Journal of Hepatology, 10.1016/j.jhep.2016.08.024, 66, 1, (132-141), (2017).
- Paul Richards, Sarah Ourabah, Jacques Montagne, Anne-Françoise Burnol, Catherine Postic and Sandra Guilmeau, MondoA/ChREBP: The usual suspects of transcriptional glucose sensing; Implication in pathophysiology, Metabolism, 70, (133), (2017).
- Yasir S. Elhassan, Andrew A. Philp and Gareth G. Lavery, Targeting NAD+ in Metabolic Disease: New Insights Into an Old Molecule, Journal of the Endocrine Society, 10.1210/js.2017-00092, 1, 7, (816-835), (2017).
- Ning Zhang, Yan Hu, Chunchun Ding, Wenjing Zeng, Wen Shan, Hui Fan, Yan Zhao, Xue Shi, Lili Gao, Ting Xu, Ruiwen Wang, Dongyan Gao and Jihong Yao, Salvianolic acid B protects against chronic alcoholic liver injury via SIRT1-mediated inhibition of CRP and ChREBP in rats, Toxicology Letters, 10.1016/j.toxlet.2016.12.010, 267, (1-10), (2017).
- Deqiang Zhang, Xin Tong, Kyle VanDommelen, Neil Gupta, Kenneth Stamper, Graham F. Brady, Zhuoxian Meng, Jiandie Lin, Liangyou Rui, M. Bishr Omary and Lei Yin, Lipogenic transcription factor ChREBP mediates fructose-induced metabolic adaptations to prevent hepatotoxicity, Journal of Clinical Investigation, 127, 7, (2855), (2017).
- Aya Abdul-Wahed, Sandra Guilmeau and Catherine Postic, Sweet Sixteenth for ChREBP: Established Roles and Future Goals, Cell Metabolism, 10.1016/j.cmet.2017.07.004, 26, 2, (324-341), (2017).
- Alison Iroz, Alexandra Montagner, Fadila Benhamed, Françoise Levavasseur, Arnaud Polizzi, Elodie Anthony, Marion Régnier, Edwin Fouché, Céline Lukowicz, Michèle Cauzac, Emilie Tournier, Marcio Do-Cruzeiro, Martine Daujat-Chavanieu, Sabine Gerbal-Chalouin, Véronique Fauveau, Solenne Marmier, Anne-Françoise Burnol, Sandra Guilmeau, Yannick Lippi, Jean Girard, Walter Wahli, Renaud Dentin, Hervé Guillou and Catherine Postic, A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response, Cell Reports, 21, 2, (403), (2017).
- Bhavna N. Desai, Garima Singhal, Mikiko Watanabe, Darko Stevanovic, Thomas Lundasen, ffolliott M. Fisher, Marie L. Mather, Hilde G. Vardeh, Nicholas Douris, Andrew C. Adams, Imad A. Nasser, Garret A. FitzGerald, Jeffrey S. Flier, Carsten Skarke and Eleftheria Maratos-Flier, Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury, Molecular Metabolism, 10.1016/j.molmet.2017.08.004, 6, 11, (1395-1406), (2017).
- Audrey M. Neyrinck, Usune Etxeberria, Bernard Taminiau, Georges Daube, Matthias Hul, Amandine Everard, Patrice D. Cani, Laure B. Bindels and Nathalie M. Delzenne, Rhubarb extract prevents hepatic inflammation induced by acute alcohol intake, an effect related to the modulation of the gut microbiota, Molecular Nutrition & Food Research, 61, 1, (2016).
- Karim Gariani, Keir J. Menzies, Dongryeol Ryu, Casey J. Wegner, Xu Wang, Eduardo R. Ropelle, Norman Moullan, Hongbo Zhang, Alessia Perino, Vera Lemos, Bohkyung Kim, Young‐Ki Park, Alessandra Piersigilli, Tho X. Pham, Yue Yang, Chai Siah Ku, Sung I. Koo, Anna Fomitchova, Carlos Cantó, Kristina Schoonjans, Anthony A. Sauve, Ji‐Young Lee and Johan Auwerx, Eliciting the mitochondrial unfolded protein response by nicotinamide adenine dinucleotide repletion reverses fatty liver disease in mice, Hepatology, 63, 4, (1190-1204), (2015).
- Cynthia Ju and Suthat Liangpunsakul, Role of hepatic macrophages in alcoholic liver disease, Journal of Investigative Medicine, 64, 6, (1075), (2016).
- Richard J.W. Wilkin, Patricia F. Lalor, Richard Parker and Philip N. Newsome, Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease, The American Journal of Pathology, 10.1016/j.ajpath.2015.12.003, 186, 4, (748-760), (2016).
- Jung Hwan Yu, Su Jin Song, Ara Kim, Yoonjeong Choi, Jo Woon Seok, Hyo Jung Kim, Yoo Jeong Lee, Kwan Sik Lee and Jae-woo Kim, Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis, Scientific Reports, 6, 1, (2016).
- Lian-Yun Chen, Qin Chen, Yi-Feng Cheng, Huan-Huan Jin, De-Song Kong, Feng Zhang, Li Wu, Jiang-juan Shao and Shi-Zhong Zheng, Diallyl trisulfide attenuates ethanol-induced hepatic steatosis by inhibiting oxidative stress and apoptosis, Biomedicine & Pharmacotherapy, 79, (35), (2016).
- Suthat Liangpunsakul, Carbohydrate‐responsive element‐binding protein, Sirtuin 1, and ethanol metabolism: A complicated network in alcohol‐induced hepatic steatosis, Hepatology, 62, 4, (994-996), (2015).
- Jin Gu, Yongxian Zhang, Daqian Xu, Zilong Zhao, Yuxue Zhang, Yi Pan, Peijuan Cao, Zhenzhen Wang and Yan Chen, Ethanol-induced hepatic steatosis is modulated by glycogen level in the liver, Journal of Lipid Research, 56, 7, (1329), (2015).
- Peng Sun, Shun-Zong Song, Shuang Jiang, Xia Li, You-Li Yao, Yan-Ling Wu, Li-Hua Lian and Ji-Xing Nan, Salidroside Regulates Inflammatory Response in Raw 264.7 Macrophages via TLR4/TAK1 and Ameliorates Inflammation in Alcohol Binge Drinking-Induced Liver Injury, Molecules, 10.3390/molecules21111490, 21, 11, (1490), (2016).
